TBC and COVID: an interplay between two infections
Giuseppe Murdaca1,2, Francesca Paladin1,2, Gloria Mangini1,2
1Department of Internal Medicine, University of Genoa, Genoa, Italy.
Coinfection with SARS-CoV-2 (COVID-19) and Mycobacterium tuberculosis (TB) presents a significant clinical challenge. Early, standardized screening is crucial for managing this severe respiratory condition and improving patient outcomes.
Area of Science:
- Immunology
- Infectious Diseases
- Respiratory Medicine
Background:
- The COVID-19 pandemic highlights the clinical significance of co-infection with Mycobacterium tuberculosis (TB).
- These two pathogens interact via specific immunopathological mechanisms, leading to severe respiratory illness and increased mortality.
- Co-infection poses a considerable clinical and diagnostic challenge.
Conclusions:
- Early and standardized screening for SARS-CoV-2 and TB co-infection is critical.
- Multidisciplinary approaches and vaccine prevention are vital for managing this dual infection.
- Addressing co-infection promptly improves clinical and therapeutic outcomes.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia II: Pathophysiology
